Cadrenal Therapeutics Inc (CVKD)
0.4103
-0.02
(-4.60%)
USD |
NASDAQ |
May 17, 16:00
0.4103
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Total Return Price: 0.411 for May 17, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.411 |
| May 16, 2024 | 0.4301 |
| May 15, 2024 | 0.4434 |
| May 14, 2024 | 0.4405 |
| May 13, 2024 | 0.4401 |
| May 10, 2024 | 0.46 |
| May 09, 2024 | 0.4854 |
| May 08, 2024 | 0.4907 |
| May 07, 2024 | 0.48 |
| May 06, 2024 | 0.50 |
| May 03, 2024 | 0.4905 |
| May 02, 2024 | 0.465 |
| May 01, 2024 | 0.4545 |
| April 30, 2024 | 0.44 |
| April 29, 2024 | 0.4511 |
| April 26, 2024 | 0.4305 |
| April 25, 2024 | 0.4236 |
| April 24, 2024 | 0.4284 |
| April 23, 2024 | 0.4265 |
| April 22, 2024 | 0.4073 |
| April 19, 2024 | 0.4016 |
| April 18, 2024 | 0.4298 |
| April 17, 2024 | 0.4217 |
| April 16, 2024 | 0.3899 |
| April 15, 2024 | 0.405 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.4127 |
| April 11, 2024 | 0.436 |
| April 10, 2024 | 0.4423 |
| April 09, 2024 | 0.4087 |
| April 08, 2024 | 0.51 |
| April 05, 2024 | 0.559 |
| April 04, 2024 | 0.6081 |
| April 03, 2024 | 0.598 |
| April 02, 2024 | 0.619 |
| April 01, 2024 | 0.619 |
| March 28, 2024 | 0.61 |
| March 27, 2024 | 0.64 |
| March 26, 2024 | 0.6486 |
| March 25, 2024 | 0.63 |
| March 22, 2024 | 0.65 |
| March 21, 2024 | 0.63 |
| March 20, 2024 | 0.60 |
| March 19, 2024 | 0.57 |
| March 18, 2024 | 0.56 |
| March 15, 2024 | 0.588 |
| March 14, 2024 | 0.5948 |
| March 13, 2024 | 0.586 |
| March 12, 2024 | 0.58 |
| March 11, 2024 | 0.6508 |
| March 08, 2024 | 0.6696 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.3899
Minimum
Apr 16 2024
4.12
Maximum
Jan 20 2023
1.058
Average
0.7922
Median
Total Return Price Benchmarks
| CEL-SCI Corp | 1.27 |
| AIM ImmunoTech Inc | 0.403 |
| IGC Pharma Inc | 0.56 |
| NovaBay Pharmaceuticals Inc | 0.1186 |
| Protalix BioTherapeutics Inc | 1.14 |